Add to Basket
Order hotline:
+1 404 474 4654
+1 888 205 9894 (TF)

CD45RO (CD45RO) antibody

Antigen

CD45RO (CD45RO)

Clonality Monoclonal (UCHL1)
Host
Alternatives

Mouse

Reactivity
Alternatives

Human

Application
Alternatives Immunohistochemistry (IHC)
3 references available
Catalog no. ABIN96778
Quantity 1ml  (100ug/ml approximately)  (Variants)
Price 259.00 $   Plus shipping costs $35.00
Shipping to
Availability Ships within 5 Business Days

Additional Information

Alternative name CD45RO
Immunogen BALB/C mice were immunized with IL-2 dependent T cell line, CA1.
Format Supernatant
Isotype IgG2a kappa  (Matching secondary antibodies)
Clone UCHL1
Specificity This antibody reacts with a 180 kD glycoprotein of CD45 family, occurring on most thymocytes and activated T cells but only on the portion of the resting T cells. It reacts with most thymocytes, a subpopulation of resting cells within both the CD4 and CD8 subsets and mature activated T cells.

Application Details

Application Notes Titer/Working Dilution: This antibody may be diluted to a titer of 1:25-1:50 in an ABC method. However, depending on the staining conditions employed, we suggest that final dilution should be determined by the user. Staining Protocol: We suggest an incubation period of 30 minutes at room temperature. However, depending upon the fixation conditions and the staining system employed, optimal incubation should be determined by the user. Suitable for formalin/paraffin tissues. Positive Control: Tonsil. Cellular localization: Cell membrane
Concentration 100ug/ml approximately
Buffer This antibody is supplied as purified immunoglobulin containing sodium azide as preservative.
Storage Store the antibody at 2-8o c. Do not use it beyond the expiration date stated on the label.
Research Area CD Antigens
Restrictions For Research Use. CE-certified for In Vitro Diagnostics (IVD) Use in the European Union

Publications

Publications Terry, Brown, Beverley: "The monoclonal antibody, UCHL1, recognizes a 180,000 MW component of the human leucocyte-common antigen, CD45." in: Immunology, Vol. 64, Issue 2, pp. 331-6, 1988 (PubMed).

Hall, DArdenne, Butler et al.: "New marker of B lymphocytes, MB2: comparison with other lymphocyte subset markers active in conventionally processed tissue sections." in: Journal of clinical pathology, Vol. 40, Issue 2, pp. 151-6, 1987 (PubMed).

Magatti, De Munari, Vertua et al.: "Human amnion mesenchyme harbors cells with allogeneic T-cell suppression and stimulation capabilities." in: Stem cells (Dayton, Ohio), Vol. 26, Issue 1, pp. 182-92, 2008 (PubMed).